From harnessing stem cells and exosomes to developing bioengineered ingredients, the beauty industry is being revolutionized.

The FDA lacks direct oversight of natural medical cannabis products due to its classification as a Schedule I substance.

Elon Musk's Neuralink has achieved a major milestone with FDA authorization for its first human clinical trials.